Global Lipid Contract Manufacturing 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092417929

Publication Date:

September 26, 2024

Pages:

109

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Liposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
The global Lipid Contract Manufacturing market size was valued at US$ 856 million in 2023 and is forecast to a readjusted size of USD 800 million by 2030 with a CAGR of -1.0% during review period.
Global core lipid contract manufacturing companies include Merck KGaA, Exelead and Avanti Polar Lipids etc. The top 3 companies hold a share about 38%. North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%.
In terms of product, lipid nanoparticles is the largest segment with a share about 79%. And in terms of application, the largest application is commercial with a share about 67%, followed by clinical and preclinical.
This report is a detailed and comprehensive analysis for global Lipid Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Lipid Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2019-2030
Global Lipid Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Lipid Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Lipid Contract Manufacturing market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid Contract Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Lipid Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Lipid Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Liposomes
Lipid Nanoparticles
麻豆原创 segment by Application
Preclinical
Clinical
Commercial
麻豆原创 segment by players, this report covers
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lipid Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lipid Contract Manufacturing, with revenue, gross margin, and global market share of Lipid Contract Manufacturing from 2019 to 2024.
Chapter 3, the Lipid Contract Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lipid Contract Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Contract Manufacturing.
Chapter 13, to describe Lipid Contract Manufacturing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Lipid Contract Manufacturing by Type
1.3.1 Overview: Global Lipid Contract Manufacturing 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lipid Contract Manufacturing Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Liposomes
1.3.4 Lipid Nanoparticles
1.4 Global Lipid Contract Manufacturing 麻豆原创 by Application
1.4.1 Overview: Global Lipid Contract Manufacturing 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Preclinical
1.4.3 Clinical
1.4.4 Commercial
1.5 Global Lipid Contract Manufacturing 麻豆原创 Size & Forecast
1.6 Global Lipid Contract Manufacturing 麻豆原创 Size and Forecast by Region
1.6.1 Global Lipid Contract Manufacturing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lipid Contract Manufacturing 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Lipid Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Lipid Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lipid Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Lipid Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Lipid Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Precision NanoSystems
2.1.1 Precision NanoSystems Details
2.1.2 Precision NanoSystems Major Business
2.1.3 Precision NanoSystems Lipid Contract Manufacturing Product and Solutions
2.1.4 Precision NanoSystems Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Precision NanoSystems Recent Developments and Future Plans
2.2 Evonik
2.2.1 Evonik Details
2.2.2 Evonik Major Business
2.2.3 Evonik Lipid Contract Manufacturing Product and Solutions
2.2.4 Evonik Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Evonik Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Lipid Contract Manufacturing Product and Solutions
2.3.4 Merck KGaA Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Genevant Sciences
2.4.1 Genevant Sciences Details
2.4.2 Genevant Sciences Major Business
2.4.3 Genevant Sciences Lipid Contract Manufacturing Product and Solutions
2.4.4 Genevant Sciences Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Genevant Sciences Recent Developments and Future Plans
2.5 Exelead
2.5.1 Exelead Details
2.5.2 Exelead Major Business
2.5.3 Exelead Lipid Contract Manufacturing Product and Solutions
2.5.4 Exelead Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Exelead Recent Developments and Future Plans
2.6 Avanti Polar Lipids
2.6.1 Avanti Polar Lipids Details
2.6.2 Avanti Polar Lipids Major Business
2.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Product and Solutions
2.6.4 Avanti Polar Lipids Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Avanti Polar Lipids Recent Developments and Future Plans
2.7 Nippon Fine Chemical
2.7.1 Nippon Fine Chemical Details
2.7.2 Nippon Fine Chemical Major Business
2.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Product and Solutions
2.7.4 Nippon Fine Chemical Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Nippon Fine Chemical Recent Developments and Future Plans
2.8 Lipoid
2.8.1 Lipoid Details
2.8.2 Lipoid Major Business
2.8.3 Lipoid Lipid Contract Manufacturing Product and Solutions
2.8.4 Lipoid Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Lipoid Recent Developments and Future Plans
2.9 Polymun Scientific
2.9.1 Polymun Scientific Details
2.9.2 Polymun Scientific Major Business
2.9.3 Polymun Scientific Lipid Contract Manufacturing Product and Solutions
2.9.4 Polymun Scientific Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Polymun Scientific Recent Developments and Future Plans
2.10 Corden Pharma
2.10.1 Corden Pharma Details
2.10.2 Corden Pharma Major Business
2.10.3 Corden Pharma Lipid Contract Manufacturing Product and Solutions
2.10.4 Corden Pharma Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Corden Pharma Recent Developments and Future Plans
2.11 Acuitas Therapeutics
2.11.1 Acuitas Therapeutics Details
2.11.2 Acuitas Therapeutics Major Business
2.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Product and Solutions
2.11.4 Acuitas Therapeutics Lipid Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Acuitas Therapeutics Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Lipid Contract Manufacturing Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Lipid Contract Manufacturing by Company Revenue
3.2.2 Top 3 Lipid Contract Manufacturing Players 麻豆原创 Share in 2023
3.2.3 Top 6 Lipid Contract Manufacturing Players 麻豆原创 Share in 2023
3.3 Lipid Contract Manufacturing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Lipid Contract Manufacturing 麻豆原创: Region Footprint
3.3.2 Lipid Contract Manufacturing 麻豆原创: Company Product Type Footprint
3.3.3 Lipid Contract Manufacturing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Lipid Contract Manufacturing Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Lipid Contract Manufacturing 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Lipid Contract Manufacturing Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Lipid Contract Manufacturing 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Lipid Contract Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Lipid Contract Manufacturing 麻豆原创 Size by Application (2019-2030)
6.3 North America Lipid Contract Manufacturing 麻豆原创 Size by Country
6.3.1 North America Lipid Contract Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Lipid Contract Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Lipid Contract Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Lipid Contract Manufacturing 麻豆原创 Size by Country
7.3.1 Europe Lipid Contract Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Lipid Contract Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lipid Contract Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lipid Contract Manufacturing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Lipid Contract Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Lipid Contract Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Lipid Contract Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Lipid Contract Manufacturing 麻豆原创 Size by Country
9.3.1 South America Lipid Contract Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Lipid Contract Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lipid Contract Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lipid Contract Manufacturing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Lipid Contract Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Lipid Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Lipid Contract Manufacturing 麻豆原创 Drivers
11.2 Lipid Contract Manufacturing 麻豆原创 Restraints
11.3 Lipid Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Lipid Contract Manufacturing Industry Chain
12.2 Lipid Contract Manufacturing Upstream Analysis
12.3 Lipid Contract Manufacturing Midstream Analysis
12.4 Lipid Contract Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.